The European Medicines Agency (‘the Agency’), in collaboration with the Member States and the Commission, set up a portal at Union level as a single entry point for the submission of data and information relating to clinical trials (‘EU portal’), as required by Article 80, first subparagraph, of Regulation (EU) No 536/2014.
Recital 1, Decision_act (EU) 2021/1240
In forcesince 13 Jul 2021